Does RANIBIZUMAB Cause Chronic obstructive pulmonary disease? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Chronic obstructive pulmonary disease have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.2% of all adverse event reports for RANIBIZUMAB.
23
Reports of Chronic obstructive pulmonary disease with RANIBIZUMAB
0.2%
of all RANIBIZUMAB reports
5
Deaths
17
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From RANIBIZUMAB?
Of the 23 reports, 5 (21.7%) resulted in death, 17 (73.9%) required hospitalization, and 5 (21.7%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
Yes, Chronic obstructive pulmonary disease is listed as a known adverse reaction in the official FDA drug label for RANIBIZUMAB.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which RANIBIZUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE